XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Series B
Preferred Stock
Series C
Preferred Stock
Common Stock
Additional Paid In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 170 $ 7,042,846 $ (5,762,321) $ 1,280,695
Balance (in Shares) at Dec. 31, 2020 1,702,839      
Series C preferred stock issued for cash, net of offering cost 3,794,102 3,794,102
Series C preferred stock issued for cash, net of offering cost (in Shares) 4,276      
Deemed dividend upon issuance of preferred stock 1,403,997 (1,403,997)
Deemed dividend upon issuance of preferred stock (in Shares)        
Common stock warrants granted for services 83,728 83,728
Net income (loss) (930,702) (930,702)
Balance at Mar. 31, 2021 $ 170 12,324,673 (8,097,020) 4,227,823
Balance (in Shares) at Mar. 31, 2021 4,276 1,702,839      
Balance at Dec. 31, 2020 $ 170 7,042,846 (5,762,321) 1,280,695
Balance (in Shares) at Dec. 31, 2020 1,702,839      
Net income (loss)           4,992,427
Balance at Sep. 30, 2021 $ 197 12,324,646 (2,173,891) 10,150,952
Balance (in Shares) at Sep. 30, 2021 227 1,972,739      
Balance at Mar. 31, 2021 $ 170 12,324,673 (8,097,020) 4,227,823
Balance (in Shares) at Mar. 31, 2021 4,276 1,702,839      
Common stock issued for conversion of Series C preferred stock $ 27 (27)
Common stock issued for conversion of Series C preferred stock (in Shares) (4,049) 269,900      
Net income (loss) (461,990) (461,990)
Balance at Jun. 30, 2021 $ 197 12,324,646 (8,559,010) 3,765,833
Balance (in Shares) at Jun. 30, 2021 227 1,972,739      
Net income (loss) 6,385,119 6,385,119
Balance at Sep. 30, 2021 $ 197 12,324,646 (2,173,891) 10,150,952
Balance (in Shares) at Sep. 30, 2021 227 1,972,739      
Balance at Dec. 31, 2021 $ 197 12,324,646 (3,262,577) 9,062,266
Balance (in Shares) at Dec. 31, 2021 227 1,972,739      
Stock options issued as stock based compensation 45,009 45,009
Common stock issued for conversion of Series C preferred stock $ 2 (2)
Common stock issued for conversion of Series C preferred stock (in Shares) (227) 15,167      
Net income (loss)   (604,072) (604,072)
Balance at Mar. 31, 2022 $ 199 12,369,653 (3,866,649) 8,503,203
Balance (in Shares) at Mar. 31, 2022     1,987,906      
Balance at Dec. 31, 2021 $ 197 12,324,646 (3,262,577) 9,062,266
Balance (in Shares) at Dec. 31, 2021 227 1,972,739      
Net income (loss)           (2,245,720)
Balance at Sep. 30, 2022 $ 314 17,361,402 (5,508,297) 11,853,419
Balance (in Shares) at Sep. 30, 2022     3,138,797      
Balance at Mar. 31, 2022 $ 199 12,369,653 (3,866,649) 8,503,203
Balance (in Shares) at Mar. 31, 2022     1,987,906      
Stock options issued as stock based compensation 15,112 15,112
Amortization of prepaid stock-based compensation 14,124 14,124
Net income (loss)         (658,402) (658,402)
Balance at Jun. 30, 2022 $ 199 12,398,889 (4,525,051) 7,874,037
Balance (in Shares) at Jun. 30, 2022     1,987,906      
Sale of common stock $ 115 4,940,833 4,940,948
Sale of common stock (in Shares)     1,150,000      
Rounding of share due to reverse stock split
Rounding of share due to reverse stock split (in Shares)     891      
Stock options issued as stock based compensation 7,556 7,556
Amortization of prepaid stock-based compensation 14,124 14,124
Net income (loss) (983,246) (983,246)
Balance at Sep. 30, 2022 $ 314 $ 17,361,402 $ (5,508,297) $ 11,853,419
Balance (in Shares) at Sep. 30, 2022     3,138,797